Cargando…

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer

Fibroblast growth factor receptor (FGFR) inhibitors (FGFRis) are a potential therapeutic option for squamous non-small cell lung cancer (Sq-NSCLC). Because appropriate patient selection is needed for targeted therapy, molecular profiling is key to discovering candidate biomarker(s). Multiple FGFR ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moes-Sosnowska, Joanna, Chorostowska-Wynimko, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991910/ https://www.ncbi.nlm.nih.gov/pubmed/35402233 http://dx.doi.org/10.3389/fonc.2022.780650

Ejemplares similares

FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022)

SERPINA1 and More? A Putative Genetic Contributor to Pulmonary Dysfunction in Alpha-1 Antitrypsin Deficiency
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2023)

Targeted screening programmes in COPD: how to identify individuals with α(1)-antitrypsin deficiency
por: Chorostowska-Wynimko, Joanna
Publicado: (2015)

The importance of effective registries in pulmonary diseases and how to optimize their output
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2019)

Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study
por: Schneider, Marc A., et al.
Publicado: (2022)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

A Pancancer Analysis of the Expression Landscape and Clinical Relevance of Fibroblast Growth Factor Receptor 2 in Human Cancers
por: Li, Juanni, et al.
Publicado: (2021)

Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021)

Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein
por: Lechowicz, Urszula, et al.
Publicado: (2020)

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2020)

Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls
por: Szpechcinski, A, et al.
Publicado: (2009)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
por: Janciauskiene, Sabina, et al.
Publicado: (2018)

Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer
por: Chorostowska-Wynimko, J, et al.
Publicado: (2009)

Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients
por: Janciauskiene, Sabina, et al.
Publicado: (2020)

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications
por: Lin, Lehang, et al.
Publicado: (2020)

Spontaneous and Radiation-Induced Chromosome Aberrations in Primary Fibroblasts of Patients With Pediatric First and Second Neoplasms
por: Zahnreich, Sebastian, et al.
Publicado: (2020)

Fibroblast Growth Factor Receptor 3 Amplified Metastatic Melanoma Treated With Erdafitinib
por: Sarkisian, Saro, et al.
Publicado: (2020)

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
por: Carleo, Alfonso, et al.
Publicado: (2017)

Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma
por: Hu, Xiaoshan, et al.
Publicado: (2022)

Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
por: Sahu, Priyanka, et al.
Publicado: (2023)

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
por: Friedlaender, Alex, et al.
Publicado: (2019)

Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease
por: Szpechcinski, A, et al.
Publicado: (2015)

Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL
por: Tottone, Luca, et al.
Publicado: (2019)

Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study
por: Chang, Qing, et al.
Publicado: (2021)

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer
por: Huang, Chao H., et al.
Publicado: (2016)

Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung Irradiation
por: Kocsis, Zsuzsa S., et al.
Publicado: (2022)

Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth
por: Rodrigues, Priscila Fabiana, et al.
Publicado: (2018)

Role of cancer-associated fibroblasts in the progression, therapeutic resistance and targeted therapy of oesophageal squamous cell carcinoma
por: Xue, Mengying, et al.
Publicado: (2023)

LncRNA-AC02278.4 Is a Novel Prognostic Biomarker That Promotes Tumor Growth and Metastasis in Lung Adenocarcinoma
por: Chen, Xin, et al.
Publicado: (2022)

KRAS Mutations in Squamous Cell Carcinomas of the Lung
por: Acker, Fabian, et al.
Publicado: (2021)

Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
por: Kim, Young Saing, et al.
Publicado: (2018)

A DNA Aptamer That Inhibits the Aberrant Signaling of Fibroblast Growth Factor Receptor in Cancer Cells
por: Eguchi, Akihiro, et al.
Publicado: (2021)

Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma
por: Minaei, Elahe, et al.
Publicado: (2022)

The role of fibroblast growth factor 18 in cancers: functions and signaling pathways
por: Zhou, Yiming, et al.
Publicado: (2023)

Cryptogenic organizing pneumonia—Results of treatment with clarithromycin versus corticosteroids—Observational study
por: Radzikowska, Elżbieta, et al.
Publicado: (2017)

Alpha-1 Antitrypsin Z Variant (AAT PI*Z) as a Risk Factor for Intrahepatic Cholestasis of Pregnancy
por: Kosinski, Przemyslaw, et al.
Publicado: (2021)

Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
por: Almangush, Alhadi, et al.
Publicado: (2021)

Development and validation of a novel fibroblast scoring model for lung adenocarcinoma
por: Wei, Shiyou, et al.
Publicado: (2022)

Targeting Genomic Alterations in Squamous Cell Lung Cancer
por: Mantripragada, Kalyan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ovigm4itpc2r455v75fm8rdja7